Article Details
Retrieved on: 2021-01-20 04:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tanvex BioPharma is a smaller company with a market capitalization of NT$11b, so it may still be flying under the radar of many institutional investors.
Article found on: simplywall.st
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here